MIR1245A: A Potential Drug Target and Biomarker (G100302219)
MIR1245A: A Potential Drug Target and Biomarker
MIR1245A is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the miRNA-protein complex, which plays a critical role in regulating gene expression. Several studies have identified MIR1245A as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.
The miRNA-protein complex is a large family of non-coding RNAs that are involved in post-transcriptional gene regulation. These RNAs interact with protein-protein interactions to control the stability and translation of target genes. MIR1245A is a member of the MIR12 family of miRNAs, which are known for their ability to target genes involved in cell growth, differentiation, and survival.
MIR1245A has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. In cancer, MIR1245A has been shown to be downregulated in various tissues and to be a potential therapeutic target. For example, studies have shown that MIR1245A is downregulated in various breast cancer tissues and that overexpression of MIR1245A has been shown to promote the growth and survival of breast cancer cells.
In neurodegenerative diseases, MIR1245A has been shown to be involved in the development and progression of several diseases, including Alzheimer's disease and Parkinson's disease. Studies have shown that MIR1245A is expressed in the brains of individuals with Alzheimer's disease and that overexpression of MIR1245A has been shown to contribute to the development of neurodegenerative diseases.
In cardiovascular diseases, MIR1245A has been shown to be involved in the regulation of several cardiovascular risk factors, including blood pressure, cholesterol levels, and the expression of pro-inflammatory genes. Studies have shown that MIR1245A is expressed in the hearts of individuals with cardiovascular disease and that overexpression of MIR1245A has been shown to contribute to the development of cardiovascular disease.
In addition to its potential therapeutic applications, MIR1245A is also a potential biomarker for several diseases. The expression of MIR1245A has been shown to be reduced in a variety of tissues and conditions, including cancer, neurodegenerative diseases, and cardiovascular disease. This suggests that MIR1245A may be a useful biomarker for these diseases and that its levels may be able to be used as a diagnostic tool.
Overall, MIR1245A is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role in these conditions and to develop effective therapies based on its targeting.
Protein Name: MicroRNA 1245a
More Common Targets
MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2
